Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stanley Kwan"'
Autor:
Jessica E. Atwell, William S. Probert, Angela Nossoff, Janet Ely, Kimmi N. Schrader, Stanley Kwan
Publikováno v:
Journal of Clinical Microbiology. 46:3228-3231
A comparative analysis of the Bordetella pertussis , B. bronchiseptica , and B. parapertussis genome assemblies permitted the identification of regions with significant sequence divergence and the design of two new real-time PCR assays, BP283 and BP4
Autor:
Nathalie A. Johnson, Kevin P. Callahan, Stanley Kwan, Lu Yao, Torsten Holm Nielsen, Nicolas Garnier, Craig T. Jordan, Koren K. Mann, Eftihia Cocolakis, Sarit Assouline, Eric Paquet, Wilson H. Miller, Robert A. Morgan, Josée Hébert
Publikováno v:
Frontiers in Pharmacology, Vol 4 (2013)
Frontiers in Pharmacology
Frontiers in Pharmacology
Acute myeloid leukemia (AML) with inversion of chromosome 3 is characterized by overexpression of EVI1 and carries a dismal prognosis. Arsenic-containing compounds have been described to be efficacious in malignancies overexpressing EVI1. Here, we de
Autor:
Nathalie A. Johnson, Eftihia Cocolakis, Stanley Kwan, Josée Hébert, Torsten Holm Nielsen, Nicolas Garnier, Wilson H. Miller, Koren K. Mann, Robert A. Morgan
Publikováno v:
Cancer Research. 72:1696-1696
Activation of EVI1, due to chromosomal translocation, inversion or transcriptional upregulation, occurs in 8-10% of AML and results in both activation and repression of specific gene sets. Importantly, the tumor suppressor PTEN is repressed by EVI1.
Publikováno v:
Cancer Research. 72:4890-4890
Arsenic trioxide (ATO) is an effective treatment for acute promyelocytic leukemia (APL). While it is undergoing clinical trials for numerous malignancies including multiple myeloma, myelodysplastic syndrome, lymphoma and solid tumors, it has demonstr
Autor:
Stanley Kwan, Robert A. Morgan, Eftihia Cocolakis, Torsten Holm Nielsen, Nicolas Garnier, Koren K. Mann, Nathalie A. Johnson, Wilson H. Miller, Josée Hébert
Publikováno v:
Blood. 118:4269-4269
Abstract 4269 Ecotropic viral integration site 1 (EVI1) is a critical oncogene driving a subset of myeloid malignancies and overexpression of EVI1 predicts an extremely poor prognosis in both adult and pediatric AML patient populations. Activation of
Autor:
Bertha Tan, Akiko Tanabe, David Keung, Stanley Kwan, Leo Wang, Zhang Zhao Bin, Yong CheeSeng cheeseng.yong@basf.com
Publikováno v:
Asia Pacific Coatings Journal. Feb2014, Vol. 27 Issue 1, p16-19. 3p.